°®¶¹´«Ã½

Andrew D. Yurochko, Ph.D., received a B.S. in biochemistry, a B.S. in biology and a Ph.D. in the immunology Section of the Department of Biological Sciences at Virginia Tech. His Ph.D. focused on how tumor growth influences macrophage function. His postdoctoral training was at the Lineberger Comprehensive Cancer Center at University of North Carolina, in Steven Haskill’s laboratory, on molecular understanding of human monocyte inflammatory biology, where he was involved in the discovery and cloning of IkBa. He also completed postdoctoral training in Eng-Shang Huang’s laboratory on the pathobiology of HCMV infection and the role monocytes play in viral spread and disease. Yurochko’s research has focused on how functional changes in immune cells (monocytes, macrophages and bone marrow progenitor cells) are involved in human disease.

He is a professor of microbiology and immunology, the Carroll Feist Endowed Chair in Viral Oncology, Director/PI of the Center of Applied Immunology and Pathological Processes at Louisiana State University Health Services Center Shreveport and Associate Director of Research in the Feist-Weiller Cancer Center. Yurochko is investigating how HCMV infects and utilizes bone marrow progenitor cells and monocytes/macrophages to promote life-long viral persistence and how infection of these cells in vivo contributes to acute and chronic virus-mediated human disease.